1 |
Titulaer MJ , Lang B , Verschuuren JJ . Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. Lancet Neurol, 2011, 10: 1098- 1107.
doi: 10.1016/S1474-4422(11)70245-9
|
2 |
Raja SM . Lambert-Eaton myasthenic syndrome and botulism. Continuum (Minneap Minn), 2022, 28: 1596- 1614.
|
3 |
Maddison P , Lipka AF , Gozzard P , Sadalage G , Ambrose PA , Lang B , Verschuuren JJ . Lung cancer prediction in Lambert-Eaton myasthenic syndrome in a prospective cohort. Sci Rep, 2020, 10: 10546.
doi: 10.1038/s41598-020-67571-9
|
4 |
Guidon AC . Lambert-Eaton myasthenic syndrome, botulism, and immune checkpoint inhibitor-related myasthenia gravis. Continuum (Minneap Minn), 2019, 25: 1785- 1806.
|
5 |
Lipka AF , Verschuuren JJGM . Lambert-Eaton myasthenic syndrome. Handb Clin Neurol, 2024, 200: 307- 325.
|
6 |
Verschuuren JJ , Palace J , Murai H , Tannemaat MR , Kaminski HJ , Bril V . Advances and ongoing research in the treatment of autoimmune neuromuscular junction disorders. Lancet Neurol, 2022, 21: 189- 202.
doi: 10.1016/S1474-4422(21)00463-4
|
7 |
Lipka AF , Boldingh MI , van Zwet EW , Schreurs MWJ , Kuks JBM , Tallaksen CM , Titulaer MJ , Verschuuren JJGM . Long-term follow-up, quality of life, and survival of patients with Lambert-Eaton myasthenic syndrome. Neurology, 2020, 94: e511- e520.
doi: 10.1212/WNL.0000000000009130
|
8 |
Wiendl H , Abicht A , Chan A , Della Marina A , Hagenacker T , Hekmat K , Hoffmann S , Hoffmann HS , Jander S , Keller C , Marx A , Melms A , Melzer N , Müller-Felber W , Pawlitzki M , Rückert JC , Schneider-Gold C , Schoser B , Schreiner B , Schroeter M , Schubert B , Sieb JP , Zimprich F , Meisel A . Guideline for the management of myasthenic syndromes. Ther Adv Neurol Disord, 2023, 16: 17562864231213240.
doi: 10.1177/17562864231213240
|
9 |
Preston DC , Shapiro BE . Electromyography and neuromuscular disorders: clinical-electrophysiologic-ultrasound correlations. 4th ed Philadelphia: Elsevier, 2020: 661- 663.
|
10 |
Wang Q , Niu JW , Ni J , Zhu YC , Cui LY . Weakness of extremities for three and a half months, diplopia for two months and urinary urgency for one month. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2014, 14: 134- 137.
URL
|
|
王全, 牛婧雯, 倪俊, 朱以诚, 崔丽英. 四肢无力3月余视物成双2个月尿急1个月. 中国现代神经疾病杂志, 2014, 14: 134- 137.
URL
|
11 |
Li J , Mao CH , Wan XH , Peng B , Cui LY . Unsteady gait and weakness of limbs for three months. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2017, 17: 697- 702.
doi: 10.3969/j.issn.1672-6731.2017.09.014
|
|
李洁, 毛晨晖, 万新华, 彭斌, 崔丽英. 行走不稳四肢无力3个月. 中国现代神经疾病杂志, 2017, 17: 697- 702.
doi: 10.3969/j.issn.1672-6731.2017.09.014
|
12 |
Waheed W , Tandan R . Postexercise facilitation in Lambert-Eaton myasthenia syndrome. Postgrad Med J, 2019, 95: 573- 574.
doi: 10.1136/postgradmedj-2019-136843
|
13 |
Hatanaka Y , Oh SJ . Ten-second exercise is superior to 30-second exercise for post-exercise facilitation in diagnosing Lambert-Eaton myasthenic syndrome. Muscle Nerve, 2008, 37: 572- 575.
doi: 10.1002/mus.20979
|
14 |
Oh SJ , Hatanaka Y , Ito E , Nagai T . Post-exercise exhaustion in Lambert-Eaton myasthenic syndrome. Clin Neurophysiol, 2014, 125: 411- 414.
doi: 10.1016/j.clinph.2013.08.028
|
15 |
Oh SJ . Neuromuscular junction disorders beyond myasthenia gravis. Curr Opin Neurol, 2021, 34: 648- 657.
doi: 10.1097/WCO.0000000000000972
|
16 |
Punga AR , Maddison P , Heckmann JM , Guptill JT , Evoli A . Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders. Lancet Neurol, 2022, 21: 176- 188.
doi: 10.1016/S1474-4422(21)00297-0
|
17 |
Ding QY , Fang J , Guan YZ , Cui LY , Hu YF . A study on post-exercise facilitation in 11 patients with Lambert-Eaton myasthenic syndrome. Zhonghua Shen Jing Ke Za Zhi, 2016, 49: 947- 951.
doi: 10.3760/cma.j.issn.1006-7876.2016.12.008
|
|
丁青云, 方佳, 管宇宙, 崔丽英, 胡右方. Lembert-Eaton肌无力综合征患者11例运动易化试验. 中华神经科杂志, 2016, 49: 947- 951.
doi: 10.3760/cma.j.issn.1006-7876.2016.12.008
|
18 |
O'Neill JH , Murray NM , Newsom-Davis J . The Lambert-Eaton myasthenic syndrome: a review of 50 cases. Brain, 1988, 111 (Pt 3): 577- 596.
|
19 |
Guan YZ , Cui LY , Zhang JB , Liu MS , Wang H . Clinical and electrophysiological characteristics of Lambert-Eaton myasthenic syndrome: a retrospective study in forty-five patients. Zhonghua Shen Jing Ke Za Zhi, 2010, 43: 331- 334.
doi: 10.3760/cma.j.issn.1006-7876.2010.05.006
|
|
管宇宙, 崔丽英, 张俊保, 刘明生, 王含. Lambert-Eaton肌无力综合征45例临床及电生理回顾性分析. 中华神经科杂志, 2010, 43: 331- 334.
doi: 10.3760/cma.j.issn.1006-7876.2010.05.006
|
20 |
Crone C , Christiansen I , Vissing J . Myopathic EMG findings and type Ⅱ muscle fiber atrophy in patients with Lambert-Eaton myasthenic syndrome. Clin Neurophysiol, 2013, 124: 1889- 1892.
doi: 10.1016/j.clinph.2013.02.115
|
21 |
Komatsu T , Bokuda K , Shimizu T , Komori T , Koide R . Pseudomyopathic changes in needle electromyography in Lambert-Eaton myasthenic syndrome. Case Rep Neurol Med, 2013, ID369278.
|
22 |
Scola RH , Iwamoto FM , Ramos CS , Sanderson AM , Lopardo D , Cantarelli A , Watanabe M , Horta W , Werneck LC . Lambert-Eaton myasthenic syndrome: report of two cases. Arq Neuropsiquiatr, 1998, 56 (3A): 457- 464.
doi: 10.1590/S0004-282X1998000300017
|
23 |
Ginebaugh SP , Badawi Y , Tarr TB , Meriney SD . Neuromuscular active zone structure and function in healthy and Lambert-Eaton myasthenic syndrome states. Biomolecules, 2022, 12: 740.
doi: 10.3390/biom12060740
|
24 |
Squier M , Chalk C , Hilton-Jones D , Mills KR , Newsom-Davis J . Type 2 fiber predominance in Lambert-Eaton myasthenic syndrome. Muscle Nerve, 1991, 14: 625- 632.
doi: 10.1002/mus.880140705
|